Desktop Site
|
02 May 24 | 09:56
|
Open
Equity
SME
Eq Drv
Currency
Commodity
Corporates
Get Quote
*
Notices
|
S&P
BSE SENSEX
74,603.94
+121.16
+0.16 %
Jubilant Pharmova Ltd
681.95
8.90 ( 1.32%)
LTD- 02 May 24 | 09:55 AM
Security ID
JUBLPHARMA
Security Code
530019
Group / Index
A / S&P BSE 500
Face value
1.00
Industry
Healthcare
Category
Listed
Stock Trading
Previous Close / Open
673.05/666.10
Day's High / Low
681.95/666.10
52 Weeks High / Low
724.00/306.00
Wtd. Avg Price
677.96
Total Traded Value (Cr.)
0.14
TTQ / 2W Avg Q (Lakh)
0.02/0.38
Circuit Limits
807.65/538.45
Mkt. Cap. Full / Free Float (Cr.)
10,862.18 / 5,105.22
Market Depth
Buy
Sell
Qty
Price
Price
Qty
84
680.80
681.80
6
20
680.75
681.85
10
6
680.70
681.95
23
74
680.45
682.00
86
14
680.40
682.05
15
-
-
Corporate Announcement
Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 , Apr 30 2024 , 4:49PM
Jubilant Pharmova Announces Completion Of USFDA Audit Of Radiopharmaceuticals Manufacturing Facility At Montreal, Canada , Apr 24 2024 , 9:53PM
Closure Of Manufacturing Operations Of Solid Dosage Formulation Facility Of Jubilant Cadista Pharmaceuticals Inc., USA ('Jubilant Cadista'), A Subsidiary, Located At Salisbury, Maryland, USA. Further, Following The Status Change Of Jubilant Generics Limited'S ('JGL') Roorkee Facility By USFDA To VAI, The Company Expects The Exports From The Roorkee Facility To The US Market To Increase In A Meaningful And Gradual Manner. , Apr 18 2024 , 12:24AM
USFDA Communication , Apr 17 2024 , 2:51PM
Compliance Certificate Under Regulation 40(10) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 , Apr 10 2024 , 5:23PM
Recent Visited
8.90 ( 1.32%)